全文获取类型
收费全文 | 4517篇 |
免费 | 336篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 146篇 |
妇产科学 | 128篇 |
基础医学 | 647篇 |
口腔科学 | 156篇 |
临床医学 | 430篇 |
内科学 | 1089篇 |
皮肤病学 | 90篇 |
神经病学 | 328篇 |
特种医学 | 267篇 |
外科学 | 409篇 |
综合类 | 53篇 |
预防医学 | 419篇 |
眼科学 | 46篇 |
药学 | 244篇 |
中国医学 | 17篇 |
肿瘤学 | 393篇 |
出版年
2023年 | 29篇 |
2022年 | 54篇 |
2021年 | 91篇 |
2020年 | 53篇 |
2019年 | 103篇 |
2018年 | 93篇 |
2017年 | 87篇 |
2016年 | 95篇 |
2015年 | 142篇 |
2014年 | 192篇 |
2013年 | 211篇 |
2012年 | 243篇 |
2011年 | 235篇 |
2010年 | 152篇 |
2009年 | 147篇 |
2008年 | 190篇 |
2007年 | 236篇 |
2006年 | 211篇 |
2005年 | 206篇 |
2004年 | 180篇 |
2003年 | 207篇 |
2002年 | 181篇 |
2001年 | 127篇 |
2000年 | 161篇 |
1999年 | 111篇 |
1998年 | 64篇 |
1997年 | 66篇 |
1996年 | 43篇 |
1995年 | 56篇 |
1994年 | 38篇 |
1993年 | 39篇 |
1992年 | 90篇 |
1991年 | 78篇 |
1990年 | 62篇 |
1989年 | 73篇 |
1988年 | 60篇 |
1987年 | 45篇 |
1986年 | 55篇 |
1985年 | 45篇 |
1984年 | 35篇 |
1983年 | 30篇 |
1982年 | 25篇 |
1980年 | 17篇 |
1979年 | 16篇 |
1976年 | 23篇 |
1975年 | 13篇 |
1971年 | 14篇 |
1970年 | 16篇 |
1967年 | 13篇 |
1966年 | 15篇 |
排序方式: 共有4910条查询结果,搜索用时 15 毫秒
21.
22.
Rechtsanwalt Dr. iur. Matthias Dann LL.M. 《MedR Medizinrecht》2007,25(11):638-643
Ohne Zusammenfassung 相似文献
23.
Eugenia Arias Horacio Martinetto Marcelo Schultz Sebastian Ameriso Santiago Rivera Oscar Lossetti Gustavo Sevlever 《Diagnostic molecular pathology》2006,15(3):174-179
A polymerase chain reaction (PCR) method for the detection of the glmM gene, selected as Helicobacter pylori target sequence, was improved. While performing pathogenicity island cagA gene detection to discriminate pathogenic strains in atherosclerotic carotid samples, several cagA-positive but glmM-negative samples were found. Polymorphisms present in the region amplified in the nested PCR reaction could explain this result; primers were therefore designed to perform a seminested reaction; this modification optimized sensitivity while maintaining specificity. A real-time PCR for Helicobacter DNA detection was also setup. The combination of all 4 PCR reactions detected 83% of H. pylori DNA-positive samples in atherosclerotic carotid tissue, 64% of which were cagA gene positive. 相似文献
24.
Patricio López-Jaramillo Director Marcelo Narváez Professor rés Calle Professor José Rivera Consultant Patricio Jácome Registrar César Ruano Professor Eduardo Nava Consultant 《BJOG : an international journal of obstetrics and gynaecology》1996,103(1):33-38
Objective To elucidate the role of the L-arginine: nitric oxide pathway in pregnancy and pre-eclampsia.
Participants Pregnant women (nulliparous, age < 25 years). Normotensive pregnancy ( n = 22 ) was defined when blood pressure remained at levels of < 120/80 mmHg and there was no proteinuria. Women with pre-eclampsia ( n = 22 ) had blood pressure measurements of > 140/90 mmHg and proteinuria of > 300 mg/l. Nonpregnant normotensive women ( n = 22 ) were studied as controls.
Study Design Blood samples were taken for measurements of ionised calcium, atrial natriuretic factor, cyclic guanosine 3'5'monophophate (GMP), arginine and asymmetric dimethylarginine. Urine samples were collected for determination of cyclic GMP excretion. Cyclic GMP concentrations were also determined in 12 women with severe pre-eclampsia before and after treatment with hydralazine.
Results L-arginine, asymmetric dimethylarginine and atrial natriuretic factor were not different in any group. Cyclic GMP concentrations in plasma [0.94 (SD 0.23) nM] as well as in urine [50.1 (SD15.7)μM] were increased significantly ( P < 0.05 ) in normal pregnancy compared to nonpregnant controls [plasma mean 0.46 (SD 0.12) nM and urine mean 18.4 (SD 10.3) μM], but not in the pre-eclampsia group [plasma mean 0.48 (SD 0.10) nM and urine mean 24.1 (SD 14.5) μM]. Concentrations of cyclic GMP in plasma and urine increased significantly ( P < 0.05 ) in women treated with hydralazine.
Conclusions The differences in cyclic GMP concentrations may reflect differences in nitric oxide production. Hydralazine increases cyclic GMP concentrations in severely pre-eclamptic women. This action could explain the antihypertensive effect of hydralazine. 相似文献
Participants Pregnant women (nulliparous, age < 25 years). Normotensive pregnancy ( n = 22 ) was defined when blood pressure remained at levels of < 120/80 mmHg and there was no proteinuria. Women with pre-eclampsia ( n = 22 ) had blood pressure measurements of > 140/90 mmHg and proteinuria of > 300 mg/l. Nonpregnant normotensive women ( n = 22 ) were studied as controls.
Study Design Blood samples were taken for measurements of ionised calcium, atrial natriuretic factor, cyclic guanosine 3'5'monophophate (GMP), arginine and asymmetric dimethylarginine. Urine samples were collected for determination of cyclic GMP excretion. Cyclic GMP concentrations were also determined in 12 women with severe pre-eclampsia before and after treatment with hydralazine.
Results L-arginine, asymmetric dimethylarginine and atrial natriuretic factor were not different in any group. Cyclic GMP concentrations in plasma [0.94 (SD 0.23) nM] as well as in urine [50.1 (SD15.7)μM] were increased significantly ( P < 0.05 ) in normal pregnancy compared to nonpregnant controls [plasma mean 0.46 (SD 0.12) nM and urine mean 18.4 (SD 10.3) μM], but not in the pre-eclampsia group [plasma mean 0.48 (SD 0.10) nM and urine mean 24.1 (SD 14.5) μM]. Concentrations of cyclic GMP in plasma and urine increased significantly ( P < 0.05 ) in women treated with hydralazine.
Conclusions The differences in cyclic GMP concentrations may reflect differences in nitric oxide production. Hydralazine increases cyclic GMP concentrations in severely pre-eclamptic women. This action could explain the antihypertensive effect of hydralazine. 相似文献
25.
26.
I. C. Chi L. R. Wilkens C. B. Champion R. E. Machemer R. Rivera 《Advances in Contraception》1989,5(2):101-119
The possible effect of breastfeeding on intrauterine device (IUD) insertion events was investigated. Analysis included a total of 6493 women who enrolled in multicenter IUD clinical trials over a ten-year period. Findings indicate that breastfeeding exerts a protective effect on the incidence of moderate to severe insertional pain and reduces the need for cervical dilatation to facilitate insertion. The pain protection effect was most evident in breastfeeding women who were still in lactational amenorrhea. Subjects with amenorrhea, both breastfeeding and non-breastfeeding, had a significantly lower incidence of pain at IUD insertion than the corresponding menstruating subjects. This effect may be related to a higher secretion of beta-endorphin in the breastfeeding and lactational amenorrheic subjects.
Resumen Se investigaron en este estudio los posibles efectos del amamantamiento sobre la inserción de dispositivos intrauterinos (DIU). El estudio comprendió 6493 mujeres que participaron en ensayos clínicos en diversos centros durante un período de diez años. Los resultados indican que el amamantamiento ejerce un efecto protector contra la aparición de dolores moderados a fuertes en el momento de la inserción y reduce la necesidad de dilatar el cuello del útero para facilitar la inserción. Este efecto de protección contra el dolor predominó entre las mujeres que amamantaban y se hallaban aún en amenorrea de lactación. Las mujeres con amenorrea, tanto las que amamantaban como las que no lo hacían, señalaron un nivel de dolor significativamente menor en el momento de inserción del DIU que aquéllas cuyo ciclo menstrual se había reanudado. Este efecto puede estar relacionado con una mayor secreción de -endorfina en las mujeres en período de amamantamiento o de amenorrea de lactación.
Resumé Cette étude présente les effets possibles de l'allaitement au sein sur des phénomènes liés à l'insertion de dispositifs intra-utérins (DIU). La recherche portait 6493 femmes inscrites dans plusieurs centres pour participer à des essais cliniques pendant une période de dix ans. On a constaté que l'allaitement au sein a un effet protecteur contre l'apparition de douleurs modérées à fortes au moment de l'insertion et qu'il réduit la nécessité de dilater le col utérin en vue de faciliter l'insertion. Cet effet de protection contre les douleurs prédominait chez les femmes qui allaitaient et se trouvaient encore en aménorrhéc de lactation. Les douleurs au moment de l'insertion étaient significativement moins fréquentes au moment de la pose du DIU chez celles qui, allaitant ou non, étaient encore en période d'aménorrhée, que chez celles dont le cycle menstruel avait repris. Cet effet peut être lié à une sécrétion plus abondante de -endorphine chez les femmes en période d'allaitement ou d'aménorrhée de lactation.相似文献
27.
Erik Diaz Teresa Gonzlez-Cossío Juan Rivera Maarten D. C. Immink Ruben Dario Mendoza C. Rafael Flores 《American journal of human biology》1991,3(5):525-530
This study aims at assessing the accuracy of estimates of body composition provided by bioimpedance (BIA) equations developed for U.S. populations when applied to a sample of Guatemalan farmers. If these equations were shown to have low validity, the second objective was to develop more accurate estimates of fat-free mass (FFM). One hundred males and females 19 to 45 years of age were randomly selected from four rural communities in the Western Highlands of Guatemala. Bioimpedance equations explained 59 and 33% of the variation in FFM, with a RMSE of 2.7 and 2.8 kg in males and females, respectively. Body fat (BF) predictions had a lower R2. Using the “all possible regressions” procedure, the best subset for prediction of FFM used anthropometric and BIA variables as predictors. The best model for men and women included only anthropometric variables: 75% of the variance in FFM for men and 70% of the variance in women was explained by this model. The RMSE was 2.1 and 1.9 kg for both groups, respectively. It is concluded that FFM can be estimated from anthropometric dimensions with a high degree of accuracy and use of BIA does not provide more valid estimates. 相似文献
28.
J. KRØLL 《Scandinavian journal of immunology》1983,17(S10):171-173
29.
J. KRØLL 《Scandinavian journal of immunology》1983,17(S10):165-169
30.
J. KRØLL 《Scandinavian journal of immunology》1983,17(S10):135-139